Compare DMRA & SLVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DMRA | SLVM |
|---|---|---|
| Founded | 2011 | 1898 |
| Country | United States | United States |
| Employees | 7 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Paper |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.7B |
| IPO Year | 2020 | 2021 |
| Metric | DMRA | SLVM |
|---|---|---|
| Price | $24.76 | $39.19 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $43.00 | ★ $54.00 |
| AVG Volume (30 Days) | ★ 398.6K | 339.8K |
| Earning Date | 05-11-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 4.15% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,351,000,000.00 |
| Revenue This Year | N/A | $0.93 |
| Revenue Next Year | N/A | $1.54 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $16.50 | $35.53 |
| 52 Week High | $28.76 | $56.80 |
| Indicator | DMRA | SLVM |
|---|---|---|
| Relative Strength Index (RSI) | 58.86 | 46.86 |
| Support Level | $22.71 | $37.90 |
| Resistance Level | $27.70 | $40.26 |
| Average True Range (ATR) | 2.23 | 1.52 |
| MACD | 0.41 | -0.01 |
| Stochastic Oscillator | 85.36 | 22.82 |
Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.
Sylvamo Corp is an uncoated papers company with a broad portfolio of top-tier brands and low-cost, large-scale paper mills. It produces uncoated freesheet (UFS) for paper products such as cut size and offset paper, as well as market pulp. The company offers Copy and Printer papers, Commercial Printing papers, Converting papers, and Specialty papers. It operates in three geographical segments: Europe, Latin America, and North America. Key revenue is generated from North America.